Y.Y.MikiY.Y. i inni, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, „Science”, 266 (5182), 1994, s. 66–71, DOI: 10.1126/science.7545954, PMID: 7545954.
J.S.J.S.LeeJ.S.J.S., J.H.J.H.ChungJ.H.J.H., Diverse functions of BRCA1 in the DNA damage response, „Expert Reviews in Molecular Medicine”, 2001, 2001, s. 1–11, DOI: 10.1017/S1462399401003131, PMID: 14987363.
L.C.L.C.WuL.C.L.C. i inni, Identification of a RING protein that can interact in vivo with the BRCA1 gene product, „Nature Genetics”, 14 (4), 1996, s. 430–440, DOI: 10.1038/ng1296-430, PMID: 8944023.
K.K.SomasundaramK.K. i inni, Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1, „Nature”, 389 (6647), 1997, s. 187–190, DOI: 10.1038/38291, PMID: 9296497.
J.E.J.E.ThomasJ.E.J.E. i inni, Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1, „Journal of Biological Chemistry”, 271 (45), 1996, s. 28630–28635, DOI: 10.1074/jbc.271.45.28630, PMID: 8910495.
T.F.T.F.LaneT.F.T.F. i inni, Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice, „Genes & Development”, 9 (21), 1995, s. 2712–2722, DOI: 10.1101/gad.9.21.2712, PMID: 7590247.
S.T.S.T.MarquisS.T.S.T. i inni, The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues, „Nature Genetics”, 11 (1), 1995, s. 17–26, DOI: 10.1038/ng0995-17, PMID: 7550308.
J.M.J.M.GudasJ.M.J.M. i inni, Hormone-dependent regulation of BRCA1 in human breast cancer cells, „Cancer Research”, 55 (20), 1995, s. 4561–4565, DOI: 10.1038/ng0995-17, ISSN0008-5472, PMID: 7553629 [dostęp 2019-02-10].
C.Y.C.Y.LiuC.Y.C.Y. i inni, Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development, „Genes & Development”, 10 (14), 1996, s. 1835–1843, DOI: 10.1101/gad.10.14.1835, PMID: 8698242.
L.C.L.C.GowenL.C.L.C. i inni, Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities, „Nature Genetics”, 12 (2), 1996, s. 191–194, DOI: 10.1038/ng0296-191, PMID: 8563759.
R.R.HakemR.R. i inni, Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation, „Nature Genetics”, 16 (3), 1997, s. 298–302, DOI: 10.1038/ng0797-298, PMID: 9207798.
X.X.XuX.X. i inni, Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation, „Nature Genetics”, 22 (1), 1999, s. 37–43, DOI: 10.1038/8743, PMID: 10319859.
X.X.XuX.X. i inni, Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells, „Molecular Cell”, 3 (3), 1999, s. 389–395, DOI: 10.1016/S1097-2765(00)80466-9, PMID: 10198641.
BohdanB.GórskiBohdanB. i inni, A high proportion of founder BRCA1 mutations in Polish breast cancer families, „International Journal of Cancer”, 110 (5), 2004, s. 683–686, DOI: 10.1002/ijc.20162, PMID: 15146557.
S.A.S.A.NarodS.A.S.A. i inni, Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group, „The Lancet”, 356 (9245), 2000, s. 1876–1881, DOI: 10.1016/S0140-6736(00)03258-X, PMID: 11130383.
T.T.ByrskiT.T. i inni, Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers, „Breast Cancer Research and Treatment”, 108 (2), 2008, s. 289–296, DOI: 10.1007/s10549-007-9600-1, PMID: 17492376.
nih.gov
ncbi.nlm.nih.gov
Y.Y.MikiY.Y. i inni, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, „Science”, 266 (5182), 1994, s. 66–71, DOI: 10.1126/science.7545954, PMID: 7545954.
J.S.J.S.ChamberlainJ.S.J.S. i inni, BRCA1 maps proximal to D17S579 on chromosome 17q21 by genetic analysis, „American Journal of Human Genetics”, 52 (4), 1993, s. 792–798, PMID: 8460646, PMCID: PMC1682065.
J.S.J.S.LeeJ.S.J.S., J.H.J.H.ChungJ.H.J.H., Diverse functions of BRCA1 in the DNA damage response, „Expert Reviews in Molecular Medicine”, 2001, 2001, s. 1–11, DOI: 10.1017/S1462399401003131, PMID: 14987363.
L.C.L.C.WuL.C.L.C. i inni, Identification of a RING protein that can interact in vivo with the BRCA1 gene product, „Nature Genetics”, 14 (4), 1996, s. 430–440, DOI: 10.1038/ng1296-430, PMID: 8944023.
K.K.SomasundaramK.K. i inni, Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1, „Nature”, 389 (6647), 1997, s. 187–190, DOI: 10.1038/38291, PMID: 9296497.
J.E.J.E.ThomasJ.E.J.E. i inni, Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1, „Journal of Biological Chemistry”, 271 (45), 1996, s. 28630–28635, DOI: 10.1074/jbc.271.45.28630, PMID: 8910495.
Y.Y.ChenY.Y. i inni, BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner, „Cancer Research”, 56 (14), 1996, s. 3168–3172, PMID: 8764100.
T.F.T.F.LaneT.F.T.F. i inni, Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice, „Genes & Development”, 9 (21), 1995, s. 2712–2722, DOI: 10.1101/gad.9.21.2712, PMID: 7590247.
S.T.S.T.MarquisS.T.S.T. i inni, The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues, „Nature Genetics”, 11 (1), 1995, s. 17–26, DOI: 10.1038/ng0995-17, PMID: 7550308.
J.M.J.M.GudasJ.M.J.M. i inni, Hormone-dependent regulation of BRCA1 in human breast cancer cells, „Cancer Research”, 55 (20), 1995, s. 4561–4565, DOI: 10.1038/ng0995-17, ISSN0008-5472, PMID: 7553629 [dostęp 2019-02-10].
J.M.J.M.GudasJ.M.J.M. i inni, Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells, „Cell Growth & Differentiation”, 7 (6), 1996, s. 717–723, PMID: 8780885.
J.P.J.P.VaughnJ.P.J.P. i inni, BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells, „Cell Growth & Differentiation”, 7 (6), 1996, s. 711–715, PMID: 8780884.
C.Y.C.Y.LiuC.Y.C.Y. i inni, Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development, „Genes & Development”, 10 (14), 1996, s. 1835–1843, DOI: 10.1101/gad.10.14.1835, PMID: 8698242.
L.C.L.C.GowenL.C.L.C. i inni, Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities, „Nature Genetics”, 12 (2), 1996, s. 191–194, DOI: 10.1038/ng0296-191, PMID: 8563759.
R.R.HakemR.R. i inni, Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation, „Nature Genetics”, 16 (3), 1997, s. 298–302, DOI: 10.1038/ng0797-298, PMID: 9207798.
X.X.XuX.X. i inni, Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation, „Nature Genetics”, 22 (1), 1999, s. 37–43, DOI: 10.1038/8743, PMID: 10319859.
X.X.XuX.X. i inni, Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells, „Molecular Cell”, 3 (3), 1999, s. 389–395, DOI: 10.1016/S1097-2765(00)80466-9, PMID: 10198641.
J.S.J.S.LarsonJ.S.J.S., J.L.J.L.TonkinsonJ.L.J.L., M.T.M.T.LaiM.T.M.T., A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells, „Cancer Research”, 57 (16), 1997, s. 3351–3355, ISSN0008-5472, PMID: 9269994 [dostęp 2019-02-10].
BohdanB.GórskiBohdanB. i inni, A high proportion of founder BRCA1 mutations in Polish breast cancer families, „International Journal of Cancer”, 110 (5), 2004, s. 683–686, DOI: 10.1002/ijc.20162, PMID: 15146557.
S.A.S.A.NarodS.A.S.A. i inni, Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group, „The Lancet”, 356 (9245), 2000, s. 1876–1881, DOI: 10.1016/S0140-6736(00)03258-X, PMID: 11130383.
T.T.ByrskiT.T. i inni, Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers, „Breast Cancer Research and Treatment”, 108 (2), 2008, s. 289–296, DOI: 10.1007/s10549-007-9600-1, PMID: 17492376.
worldcat.org
J.M.J.M.GudasJ.M.J.M. i inni, Hormone-dependent regulation of BRCA1 in human breast cancer cells, „Cancer Research”, 55 (20), 1995, s. 4561–4565, DOI: 10.1038/ng0995-17, ISSN0008-5472, PMID: 7553629 [dostęp 2019-02-10].